Doctor profile · Federal record

Dr. Cynthia Osborne, MD

Medical Oncology Physician (CMS: Medical Oncology) · Dallas, TX

  • NPI 1639111503
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 30 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3410 Worth St
Dallas, TX 752462003
(214) 370-1000
fax (972) 370-1850
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
October 26, 2011
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #K7854
Medicaid (2)
TX #152184103 · TX #152184104

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1639111503. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
60,844
Distinct HCPCS
10
Medicare allowed
$1,050,910
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 13,000 49 $55
J1453 Injection, fosaprepitant, 1 mg 11,850 64 $0
J9267 Injection, paclitaxel, 1 mg 6,840 32 $0
J9299 Injection, nivolumab, 1 mg 5,680 15 $30
J9263 Injection, oxaliplatin, 0.5 mg 5,400 14 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,287 53 $0
J1756 Injection, iron sucrose, 1 mg 2,500 11 $0
J9171 Injection, docetaxel, 1 mg 1,889 14 $1
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,845 117 $0
J2469 Injection, palonosetron hcl, 25 mcg 1,110 83 $1

In context: peer comparison

Among 27 peers in Dallas Medical Oncology Physician, average services per provider: 1,011. This provider delivers 60× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,956
Transactions
23
Manufacturers
8
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 9 $3,644.60
Daiichi Sankyo INC. 4 $96.12
Genentech USA, INC. 3 $57.68
Stemline Therapeutics INC. 2 $46.01
Gilead Sciences, INC. 2 $39.54
Pfizer INC. 1 $35.69
AstraZeneca Pharmaceuticals Lp 1 $20.09
Merck Sharp & Dohme LLC 1 $16.72

By nature of payment

Consulting Fee
$3,038
Long Term Medical Supply or Device Loan
$583
Food and Beverage
$336

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
718
Patients
163
Total drug cost
$539,681
Drug Type Claims Patients Total cost
Letrozole Generic 243 65 $7,029
Anastrozole Generic 233 65 $6,409
Alendronate Sodium Generic 59 15 $467
Tamoxifen Citrate Generic 45 18 $1,160
Gabapentin Generic 34 0 $299
Olanzapine Generic 20 0 $433
Ibrance (Palbociclib) Brand 17 0 $259,107
Verzenio (Abemaciclib) Brand 17 0 $245,048
Zolpidem Tartrate Generic 14 0 $199
Entecavir Generic 13 0 $691

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Cynthia Osborne's medical specialty?
Dr. Cynthia Osborne practices Medical Oncology Physician in Dallas, TX.
Where does Dr. Cynthia Osborne practice?
Dr. Cynthia Osborne practices at 3410 Worth St, Dallas, TX 752462003. Office phone: 2143701000.
What is Dr. Cynthia Osborne's NPI?
Dr. Cynthia Osborne's National Provider Identifier (NPI) is 1639111503, issued by NPPES.
Does Dr. Cynthia Osborne accept Medicare assignment?
Yes. Dr. Cynthia Osborne accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Cynthia Osborne commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.